American Heart Journal Plus: Cardiology Research and Practice
Издатель: Elsevier · ISSN 2666-6022 · 85 статей
- Three decades of coronary intravascular ultrasound and optical coherence tomography: A structured narrative review of published bibliometric evidence and trial-driven research phases
- Adolescent anaemia as a candidate marker of cardiometabolic vulnerability: A life-course preventive cardiology perspective
- Apolipoprotein A1 as an emerging cardiovascular biomarker: A systematic review and meta-analysis of its association with cardiovascular outcomes
- AI-guided CRISPR gene editing for cardiovascular disease: Current progress, transitional challenges, and future directions
- Post-orthotopic heart transplant atrial fibrillation: From mechanisms to management, with a retrospective analysis of anticoagulation
- Cardiovascular outcomes with semaglutide versus tirzepatide in patients with obesity and atherosclerotic cardiovascular disease without diabetes
- Intracoronary hematopoietic cell injection is associated with an improvement in ventricular remodeling at five-year follow-up in patients with old myocardial scars
- SGLT2 inhibitors for peripartum cardiomyopathy: A call for a dedicated trial
- Comment on “Association of caffeine levels with myocardial perfusion during pharmacological stress cardiac magnetic resonance imaging”
- Impact of cigarette smoking and cumulative exposure on serum lipid profile: A cross-sectional study
- Comment on “Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58”
- Letter to the editor on: “Meta-analysis of the histopathological features of surgically removed aortas classified according to the SCVP and AECVP consensus documents”
- Comment on “Chronic kidney disease is associated with worse survival after revascularization in subjects with genetically diagnosed familial hypercholesterolemia and significant coronary artery disease”
- Comment on “Ticagrelor versus prasugrel following PCI in acute coronary syndromes and high-risk coronary artery disease: A meta-analysis of one-year randomized trial outcomes”
- Comment on “Multimodal ultrasound and computed tomography imaging may improve the discrimination between symptomatic and asymptomatic patients with carotid stenosis”
- Comment on “Effect of aerobic training on apoptosis biomarkers and cardiac wall stress in healthy and streptozotocin-induced diabetic male rats”
- Authors' reply to “Comment on Prospective randomized clinical trial on comprehensive cardiac rehabilitation combined with individualized cognitive training in older adults with heart failure and mild cognitive impairment”
- Comment on “Autoimmune disorders and cardiovascular disease: a matched cross-sectional analysis of disease-specific associations in Qatari primary care”
- Comment on “Early efficacy of oral lipid lowering therapy in achieving LDL-C targets following acute coronary syndrome: A real-world observational study”
- Comment on “Outcomes of isolated ostial LAD PCI versus multivessel PCI including ostial LAD lesions”
- Comment on “Health related quality of life and cardiac symptoms following admission for suspected MINOCA: A post-hoc analysis of the MINOCA-BAT randomized clinical trial”
- Comment on “Polygenic risk score for early identification of coronary artery disease in a real-world clinical setting within the Latvian patient population”
- Comment on “Proteomic markers associated with blood pressure, hypertension, and treatment-resistant hypertension”
- Comment on “The impact of an adaptive patient-centered web application on medication optimization in patients with HFrEF: Rationale and design of the SmartHF trial”
- Comment on “Public availability of trial-design and clinical-context information in contemporary lipoprotein(a)-targeted cardiovascular trials: A cross-sectional meta-research study”